Remote Patient Monitoring Industry - Regional Synopsis
The North America region remote patient monitoring market is set to dominate majority revenue share by the end of 2037. Factors such as the presence of the major key players and rising prevalence of chronic diseases, the growing demand for low-cost treatment, and increasing wireless and portable systems adoption are anticipated to propel the market revenue. Based on the data provided by the Centers for Disease Control and Prevention (CDC), it was stated that in every 10 Americans, 6 of them suffer from some sort of chronic diseases such as cancer, diabetes, stroke, and others.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Remote Patient Monitoring Market in 2025 is evaluated at USD 9.86 billion.
The global market size was worth more than USD 8.53 billion in 2024 and is poised to witness a CAGR of over 19.5%, crossing USD 86.44 billion revenue by 2037.
North America leads, backed by major key players and growing chronic disease prevalence.
The major players in the market include F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott Laboratories, Bio Telemetry, Inc., Boston Scientific Corporation, Omron Corporation, Masimo Corporation, Edward Lifesciences Corporation, Nihon Kohden Corporation, Medtronic plc.
